A Randomised, Double-Blind, Placebo-Controlled, 2-Period Cross-Over Study in Healthy Male Volunteers, to Investigate Retinal Function Following a Single 800mg Oral Dose of AZD9056
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2008
At a glance
- Drugs AZD 9056 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 21 Jul 2008 New trial record.